RecruitingNCT04799535
Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring
Sponsor
Mayo Clinic
Enrollment
550 participants
Start Date
Sep 1, 2019
Study Type
OBSERVATIONAL
Conditions
Summary
This study evaluates the effectiveness of a breast ultrasound method for the diagnosis of breast cancer. Diagnostic procedures, such as breast ultrasound, may help find and diagnose breast cancer, and may help measure a patient's response to earlier treatment. The purpose of this research is to test the effectiveness of a new investigational breast ultrasound method to detect an abnormality in the breast, and assess response to breast cancer treatment.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- AIM 1: Patient volunteers, ages \>= 18 with suspicious breast masses scheduled for breast biopsy, or at least two weeks or more after breast biopsy
- AIM 2: Patient volunteers, ages \>= 18 who have biopsy proven breast cancer and are going under neoadjuvant chemotherapy and/or endocrine therapy had their baseline MRI and/or ultrasound
Exclusion Criteria1
- Patients with breast implants or any condition that does not allow proper use of ultrasound (US)
Interventions
PROCEDUREUltrasound
Undergo breast ultrasound
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04799535
Related Trials
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
NCT06418204467 locations
The Vanguard Study: Testing a New Way to Screen for Cancer
NCT0699589836 locations
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
NCT059415204 locations
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
NCT0618475011 locations
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
NCT061953063 locations